Completed
Age-Related Eye Disease Study AREDS
Led by National Eye Institute (NEI) · Updated on 2009-01-23
4757
Participants Needed
N/A
Research Sites
269 weeks
Total Duration
On this page
Sponsors
N
National Eye Institute (NEI)
Lead Sponsor
B
Bausch & Lomb Incorporated
Collaborating Sponsor
AI-Summary
What this Trial Is About
To assess the clinical course, prognosis, and risk factors of age-related macular degeneration (AMD) and cataract. To evaluate, in randomized clinical trials, the effects of pharmacologic doses of (1) antioxidants and zinc on the progression of AMD and (2) antioxidants on the development and progression of lens opacities.
CONDITIONS
Brief Title
Age-Related Eye Disease Study (AREDS)
Who Can Participate
Eligibility Criteria
Men and women between the ages of 55 and 80 years whose macular status ranges from no evidence of AMD in either eye to relatively severe disease with vision loss in one eye but good vision in the fellow eye (20/30 or better) are eligible for the study provided that their ocular media are clear enough to allow good fundus photography.
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here